Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus. | Front Immunol | 2022 | 35663943 | PubTator, text mining | PubMed |
| New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report. | Clin Case Rep | 2022 | 35662780 | PubTator, text mining | PubMed |
| Gene expression and clinical outcomes after dietary treatment for eosinophilic esophagitis: a prospective study. | Neurogastroenterol Motil | 2022 | 35661487 | PubTator, text mining | PubMed |
| [A Case of Pemphigus Vulgaris Showing a Local Nose Erosion as the First Clinical Manifestation]. | J UOEH | 2022 | 35660688 | PubTator, text mining | PubMed |
| A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity. | Sci Rep | 2022 | 35654912 | PubTator, text mining | PubMed |
| Difficult and complicated oral ulceration: an expert consensus guideline for diagnosis. | Int J Oral Sci | 2022 | 35650189 | PubTator, text mining | PubMed |
| Serological Biomarkers and Their Detection in Autoimmune Bullous Skin Diseases. | Dermatol Pract Concept | 2022 | 35646449 | PubTator, text mining | PubMed |
| Clinical significance of umbilical region involvement in pemphigus vulgaris in a series of 81 ethnic Poles: a comparative analysis of the distribution of lesions in two infrequent locations. | Postepy Dermatol Alergol | 2022 | 35645684 | PubTator, text mining | PubMed |
| Pemphigus Foliaceus Autoantibodies Induce Redistribution Primarily of Extradesmosomal Desmoglein 1 in the Cell Membrane. | Front Immunol | 2022 | 35634274 | PubTator, text mining | PubMed |
| The Biology of Varicella-Zoster Virus Replication in the Skin. | Viruses | 2022 | 35632723 | PubTator, text mining | PubMed |
| Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus. | Viruses | 2022 | 35632621 | PubTator, text mining | PubMed |
| Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs. | Metabolites | 2022 | 35629903 | PubTator, text mining | PubMed |
| Sacral Dimple, Conjunctiva, and Nipple as Less Obvious Pemphigus Vulgaris Locations around Natural Body Orifices: A Report of Three Cases. | J Clin Med | 2022 | 35628981 | PubTator, text mining | PubMed |
| Clinical, Histopathologic, and Immunohistochemical Features of Patients with IgG/IgA Pemphigus. | Biomedicines | 2022 | 35625932 | PubTator, text mining | PubMed |
| Loricrin at the Boundary between Inside and Outside. | Biomolecules | 2022 | 35625601 | PubTator, text mining | PubMed |
Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men. | Int J Womens Dermatol | 2022 | 35620025 | PubTator, text mining | PubMed |
| What protein kinases are crucial for acantholysis and blister formation in pemphigus vulgaris? A systematic review. | J Cell Physiol | 2022 | 35616233 | PubTator, text mining | PubMed |
| The interferon-β/STAT1 axis drives the collective invasion of skin squamous cell carcinoma with sealed intercellular spaces. | Oncogenesis | 2022 | 35606369 | PubTator, text mining | PubMed |
| Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report. | Acta Derm Venereol | 2022 | 35604239 | PubTator, text mining | PubMed |
| Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study. | Front Immunol | 2022 | 35592312 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=36